(Health-NewsWire.Net, December 09, 2016 ) Contract manufacturing involves outsourcing manufacturing products to organizations, which helps the organizations offer the same services at a relatively lower cost. Typically, in the pharmaceutical and biotechnology sectors, the sourcing companies seek contract manufacturing services to restructure their resource deployment toward high skill areas such as R&D and marketing. Contract manufacturing has potential growth opportunities in emerging countries such as India and China.
Publisher's analysts forecast the global pharmaceutical contract manufacturing market to grow at a CAGR of 6.91% during the period 2016-2020. For more information about this report: http://www.reportsweb.com/global-pharmaceutical-contract-manufacturing-market-2016-2020 Covered in this report The report covers the present scenario and the growth prospects of the global pharmaceutical contract manufacturing market for 2016-2020. To calculate the market size, the report considers the revenue generated from various pharmaceutical drug manufacturing outsourcing activities.
The market is divided into the following segments based on geography: -Americas -APAC -EMEA
Publisher's report, Global Pharmaceutical Contract Manufacturing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors -Catalent -Lonza -Pfizer CentreOne
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001462889/sample .
Other prominent vendors -Abbott -Aenova -Amgen -Apotex -Aspen -AstraZeneca -Aurobindo Pharma -Baxter -BERLIN-CHEMIE -Biocon -Biogen -Boehringer Ingelheim -Celltrion -Cipla -Coherus Biosciences -Daiichi Sankyo -Dr. Reddy's Laboratories -Eli Lilly -Emcure Pharmaceuticals -Eurofarma Laboratories -Fareva -Gedeon Richter -Gilead Sciences -GlaxoSmithKline (GSK) -Hospira -Impax Laboratories -Intas Pharmaceuticals -Janssen Pharmaceuticals -Lupin -Merck -Mitsubishi Tanabe Pharma -Momenta Pharmaceuticals -Natco Pharma -Nexus Pharmaceuticals -Novo Nordisk -Orchid Chemicals & Pharmaceuticals -Par Pharmaceutical -Parenteral Drugs India -Patheon -Piramal -Roche Holding -Sanofi -Synthon -Teva Pharmaceuticals -Valeant Pharmaceuticals -Zentiva -Zhejiang Huahai Pharmaceutical -Zydus Cadila
Market driver -High number of US FDA-approved manufacturing facilities in emerging countries. -For a full, detailed list, view our report
Market challenge -Capacity utilization issues and lack of information integration. -For a full, detailed list, view our report
Market trend -Huge demand for next-generation biologics. -For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001462889/buying .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|